These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 21196208)
1. Bone morphogenetic protein and bone metastasis, implication and therapeutic potential. Ye L; Mason MD; Jiang WG Front Biosci (Landmark Ed); 2011 Jan; 16(3):865-97. PubMed ID: 21196208 [TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins and their receptor signaling in prostate cancer. Ye L; Lewis-Russell JM; Kyanaston HG; Jiang WG Histol Histopathol; 2007 Oct; 22(10):1129-47. PubMed ID: 17616940 [TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review). Ye L; Bokobza SM; Jiang WG Int J Mol Med; 2009 Nov; 24(5):591-7. PubMed ID: 19787192 [TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins and its receptors; therapeutic targets in cancer progression and bone metastasis? Buijs JT; Petersen M; van der Horst G; van der Pluijm G Curr Pharm Des; 2010; 16(11):1291-300. PubMed ID: 20166979 [TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins. Chen D; Zhao M; Mundy GR Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726 [TBL] [Abstract][Full Text] [Related]
6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362 [TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins and inner ear development. Ma JY; You D; Li WY; Lu XL; Sun S; Li HW J Zhejiang Univ Sci B; 2019 Feb.; 20(2):131-145. PubMed ID: 30112880 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463 [TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy. Li B Endocr Metab Immune Disord Drug Targets; 2008 Sep; 8(3):208-19. PubMed ID: 18782017 [TBL] [Abstract][Full Text] [Related]
11. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Yang S; Zhong C; Frenkel B; Reddi AH; Roy-Burman P Cancer Res; 2005 Jul; 65(13):5769-77. PubMed ID: 15994952 [TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway. Ye L; Kynaston H; Jiang WG J Urol; 2009 Jun; 181(6):2749-59. PubMed ID: 19375725 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction. Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311 [TBL] [Abstract][Full Text] [Related]
14. Secreted BMP antagonists and their role in cancer and bone metastases. Todd GM; Gao Z; Hyvönen M; Brazil DP; Ten Dijke P Bone; 2020 Aug; 137():115455. PubMed ID: 32473315 [TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins and their receptors in the eye. Wordinger RJ; Clark AF Exp Biol Med (Maywood); 2007 Sep; 232(8):979-92. PubMed ID: 17720944 [TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies. Ye L; Jiang WG Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195 [TBL] [Abstract][Full Text] [Related]
17. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells. Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235 [TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance. Zabkiewicz C; Resaul J; Hargest R; Jiang WG; Ye L Endocr Relat Cancer; 2017 Oct; 24(10):R349-R366. PubMed ID: 28733469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]